Literature DB >> 22483665

Hendra and Nipah viruses: why are they so deadly?

Glenn A Marsh1, Lin-Fa Wang.   

Abstract

Henipavirus, including Hendra and Nipah viruses, is a group of emerging bat-borne paramyxoviruses which were responsible for severe disease outbreaks in humans, horses and pigs. The mortality rate of human infection varies between 50 and 100%, making them one of the most deadly viruses known to infect humans. Its use of highly conserved cell surface molecules (ephrin) as entry receptors and its highly effective replication and fusion strategies are believed to be important characteristics responsible for its high pathogenicity. Henipavirus also encodes multiple accessory proteins which play a key role in evasion of host innate immune responses. Our recent study on the mechanism of IFN antagonism by henipaviruses indicated that a better understanding of the virus-host interaction provides great potential to develop new therapeutic strategies against these viruses. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22483665     DOI: 10.1016/j.coviro.2012.03.006

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  39 in total

1.  Emerging infections of the central nervous system.

Authors:  Jennifer Lyons; Justin McArthur
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

2.  Transmembrane Domain Dissociation Is Required for Hendra Virus F Protein Fusogenic Activity.

Authors:  Kerri Beth Slaughter; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

3.  Functional rectification of the newly described African henipavirus fusion glycoprotein (Gh-M74a).

Authors:  Olivier Pernet; Shannon Beaty; Benhur Lee
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 4.  Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.

Authors:  Jasper F W Chan; Susanna K P Lau; Kelvin K W To; Vincent C C Cheng; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

5.  Mutations in the Transmembrane Domain and Cytoplasmic Tail of Hendra Virus Fusion Protein Disrupt Virus-Like-Particle Assembly.

Authors:  Nicolás Cifuentes-Muñoz; Weina Sun; Greeshma Ray; Phuong Tieu Schmitt; Stacy Webb; Kathleen Gibson; Rebecca Ellis Dutch; Anthony P Schmitt
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

6.  Rhabdovirus-based vaccine platforms against henipaviruses.

Authors:  Drishya Kurup; Christoph Wirblich; Heinz Feldmann; Andrea Marzi; Matthias J Schnell
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

7.  A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.

Authors:  Chad E Mire; Joan B Geisbert; Krystle N Agans; Yan-Ru Feng; Karla A Fenton; Katharine N Bossart; Lianying Yan; Yee-Peng Chan; Christopher C Broder; Thomas W Geisbert
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.

Authors:  D Jochmans; S van Nieuwkoop; S L Smits; J Neyts; R A M Fouchier; B G van den Hoogen
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

9.  Promiscuous and specific recognition among ephrins and Eph receptors.

Authors:  Dandan Dai; Qiang Huang; Ruth Nussinov; Buyong Ma
Journal:  Biochim Biophys Acta       Date:  2014-07-10

10.  Henipavirus pathogenesis in human respiratory epithelial cells.

Authors:  Olivier Escaffre; Viktoriya Borisevich; J Russ Carmical; Deborah Prusak; Joseph Prescott; Heinz Feldmann; Barry Rockx
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.